In December 2013, Health Canada approved Sovaldi (sofosbuvir) for use in Canada. As a new HCV treatment drug, sofosbuvir offers great promise for shorter treatment times, and the convenience of taking one pill a day. This new treatment drug has the potential to be effective without interferon (depending on genotype) however, treatment still involves interferon and ribavirin.